Check Out What Whales Are Doing With CRSP
Portfolio Pulse from Benzinga Insights
Deep-pocketed investors have shown a bearish sentiment towards CRISPR Therapeutics (NASDAQ:CRSP), with a notable shift in options activity. Benzinga's tracking revealed 26 extraordinary options activities, with a mix of bullish and bearish sentiments, but a slight lean towards bearish with 53%. The focus is on a price band between $45.0 and $110.0. CRISPR Therapeutics, a gene editing company, has seen its stock price increase by 2.43%, reaching $74.55, with a potential overbought status indicated by the current RSI values. The next earnings report is expected in 13 days.
February 14, 2024 | 6:31 pm
News sentiment analysis
Sort by:
Ascending
NEGATIVE IMPACT
Whales show a bearish sentiment towards CRISPR Therapeutics, with a focus on a price band between $45.0 and $110.0. The stock has recently increased by 2.43%, reaching $74.55, but may be overbought.
The bearish sentiment among deep-pocketed investors, indicated by the options activity, suggests a potential short-term downside for CRSP. The focus on a specific price band and the current overbought status further support this view. However, the upcoming earnings report could introduce volatility and uncertainty, hence the slightly reduced confidence score.
CONFIDENCE 85
IMPORTANCE 90
RELEVANCE 100